天承科技(688603) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 101,527,715.09, representing a 26.77% increase compared to CNY 80,088,379.16 in the same period last year[3]. - Net profit attributable to shareholders was CNY 18,973,252.65, a 5.76% increase from CNY 17,940,505.85 year-over-year[3]. - Basic and diluted earnings per share were both CNY 0.23, reflecting a 9.52% increase from CNY 0.21 in the previous year[3]. - Total operating revenue for Q1 2025 reached ¥101,527,715.09, a 26.8% increase from ¥80,088,379.16 in Q1 2024[19]. - Net profit for Q1 2025 was ¥18,973,252.65, representing a 5.7% increase compared to ¥17,940,505.85 in Q1 2024[21]. - Basic and diluted earnings per share for Q1 2025 were both ¥0.23, up from ¥0.21 in Q1 2024[21]. Research and Development - R&D investment totaled CNY 8,550,929.23, up 76.52% from CNY 4,844,111.90 in the previous year, accounting for 8.42% of operating revenue[3]. - Research and development expenses for Q1 2025 totaled ¥8,550,929.23, an increase of 76.0% from ¥4,844,111.90 in Q1 2024[20]. Cash Flow - The net cash flow from operating activities decreased by 74.97% to CNY 8,442,781.48, primarily due to increased procurement payments[3][7]. - Cash flow from operating activities for Q1 2025 was ¥8,442,781.48, a decrease from ¥33,734,966.00 in Q1 2024[24]. - Cash inflow from investment activities totaled $888,314,754.06, an increase from $487,225,306.66 year-over-year[25]. - Cash outflow for investment activities was $682,519,077.67, compared to $557,855,800.00 in the previous period[25]. - Net cash flow from investment activities was $205,795,676.39, a significant improvement from a negative $70,630,493.34 last year[25]. - Cash outflow from financing activities amounted to $646,419.96, compared to $35,043,957.48 in the previous year[25]. - The net increase in cash and cash equivalents was $213,073,560.14, contrasting with a decrease of $71,939,484.80 in the prior period[25]. - The ending balance of cash and cash equivalents reached $389,640,470.12, up from $168,200,882.94 year-over-year[25]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,259,630,638.74, a 1.37% increase from CNY 1,242,601,122.09 at the end of the previous year[4]. - As of March 31, 2025, the company's total assets amounted to RMB 1,259,630,638.74, an increase from RMB 1,242,601,122.09 as of December 31, 2024[14]. - The total current assets reached RMB 1,136,081,954.50, compared to RMB 1,117,124,936.59 at the end of 2024, indicating a slight increase of about 1.7%[15]. - The company's inventory decreased to RMB 37,660,649.46 from RMB 39,700,591.96, reflecting a decline of approximately 5.1%[14]. - The total current liabilities were RMB 83,710,052.62, down from RMB 86,553,979.42, showing a reduction of about 3.2%[16]. - The company's non-current assets totaled RMB 123,548,684.24, a slight decrease from RMB 125,476,185.50[15]. - The total liabilities decreased to RMB 117,649,833.45 from RMB 120,794,126.20, indicating a reduction of approximately 2%[16]. - The company's accounts receivable stood at RMB 146,392,250.63, a minor decrease from RMB 149,963,568.54[14]. Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 2,814[9]. - The largest shareholder, Tiancheng Chemical Co., Ltd., holds 16.68% of the shares, totaling 14,004,259 shares[9]. - The company reported a total of 758,556 shares held in the repurchase special securities account, accounting for 0.90% of total shares[11]. - The company has not disclosed any significant changes in shareholder relationships or actions among the top shareholders[12]. Other Information - The company reported a total of CNY 2,147,703.45 in non-recurring gains and losses for the period[7]. - The weighted average return on equity increased by 0.04 percentage points to 1.68%[3]. - The company will not apply new accounting standards starting from 2025[26].